Action on Hearing Loss Logo
    Total results:
    Search
      Total results:

      It’s more important than ever to protect NHS services

      Gemma Twitchen, Senior Audiologist here at Action on Hearing loss, writes about the impact we have had on NHS audiology services and how we’re working to address some of the challenges faced now.

      By: Gemma Twitchen | 29 June 2018

      Virtually everything we do requires some form of communication, be it at work or at home, and feeling unable to express yourself is incredibly isolating. Having worked in audiology for sixteen years, I’ve witnessed first-hand the impact that hearing loss can have on day to day living and the massive impact that hearing aids can have on people’s lives. Hearing aids have been free on the NHS since its inception in 1948, in part due to campaigning from Action on Hearing Loss, then known as the National Institute of the Deaf (N.I.D), who played a key role in ensuring that hearing aids and batteries were available on the health service from the outset. More recently, however, such services have been under threat, with cuts directly aimed at hearing aids in an effort to make savings.

      Frustratingly, for many years, it has felt as though hearing loss not been taken seriously in comparison to other health conditions, despite hearing loss being the most prevalent disability globally and with numbers with hearing loss expecting to increase due to the ageing population. Hearing loss has been described as a ‘hidden epidemic’ and recent evidence suggests that hearing loss affects around half a billion people living with disabling hearing loss around the world and is the fourth most important cause of years lost through disability. In addition to this, increasing evidence links hearing loss with other co-morbidities, such as dementia. A recent Lancet Commission on dementia prevention, intervention and care identified hearing loss as the largest modifiable risk factor for dementia in people who are middle aged. However, addressed and managed hearing loss can prevent social isolation and evidence even suggests that hearing aids can reduce the risk and impact of dementia.

      In October 2015, North Staffordshire Clinical Commissioning Group (CCG) stopped providing hearing aids to those with mild hearing loss and limited provision for those with moderate hearing loss, acting against overwhelming public opinion and all clinical evidence. This was a huge blow to the sector and to those with hearing loss in the area. Following this, 13 further CCGs looked at similar proposals but following Action on Hearing Loss' engagement and intervention decided not to proceed with cuts, however we are aware of more subtle cuts occurring across England that we are keeping a close eye on and are greatly concerned about.

      It is imperative now more than ever that our NHS audiology services are protected and people can access the vital support they need for their hearing loss so that they can communicate effectively. I am delighted that we have made great strides in getting hearing loss recognised as a major public health issue both globally and nationally and as a consequence, have in recent years, seen a number of policies and initiatives to improve and protect audiology services. Action on Hearing Loss has worked with The Government, NHS England and the National Institute for Health and Care (NICE) to produce key documents such as the Action Plan on Hearing Loss, which is the first cross Government strategy for hearing loss, NHS England’s Commissioning Framework for Adult hearing loss services and the newly published NICE guidance on hearing loss.

      Recently we have celebrated the release of new NICE guideline, ‘Hearing loss in adults: assessment and management’. We campaigned for the existence of the guideline, which consists of recommendations on how to best identify, refer, diagnose, treat and manage patients with hearing loss based on the best evidence available. These guidelines specifically say that everyone whose hearing loss affects their communication should be given a hearing aid at the first possible opportunity.

      While all of these documents are available, our job now – with the help of our amazing network of campaigners across the country – is to ensure that they are implemented. It’s vital that hearing care on the NHS continues to be freely available to all who need it and that there is no postcode lottery in quality and provision.

      Recent Posts

      A day in the life of a trainer with hearing loss

      Welcome back to our blog series, ‘A day in the life of…’. Enjoy a fascinating insight into the working lives of people with different types of hearing loss, across a diverse range of careers and workplaces.

      By: Sally Bromham
      13 November 2018

      EE partnership brings unbeatable packages

      For the first time ever, selected mobile phones with EE Pay As You Go plans, tailored for people who are deaf or have hearing loss, are available from Action on Hearing Loss.

      By: Brian Burns
      17 October 2018

      REGAIN update on the progress so far and a further opportunity for people with hearing loss to take part in the trial

      A team of researchers and clinicians at UCL’s Ear Institute and the Royal National Throat Nose and Ear Hospital are delighted to announce that the REGAIN trial is approaching its first anniversary and are continuing to recruit people with hearing loss to participate in a ground breaking clinical trial to test the safety and efficacy of a new drug that aims to treat sensorineural hearing loss. The criteria for eligibility to participate in the trial has recently been broadened to include participants with hearing loss of up to 20 years duration (see below for further information).

      By: REGAIN
      16 October 2018

      Preventing hearing loss: the search for treatments

      Medicines like aminoglycoside antibiotics or cisplatin are used to combat life-threatening infections and cancer, respectively, but their use may come at the price of someone’s hearing. Several treatments to prevent the loss of hearing caused by these medicines are currently being developed. Our Translational Research Manager, Dr Carina Santos, tells us more.

      By: Dr Carina Santos
      12 October 2018